The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 08, 2017
Filed:
Aug. 17, 2015
Applicants:
Baxter International Inc., Deerfield, IL (US);
Baxter Healthcare S.a., Glattpark (Opfikon), CH;
Inventors:
John J. Barry, Northbrook, IL (US);
Andreas Goessl, Vienna, AT;
Heinz Gulle, Gross Enzersdorf, AT;
Monika Mangold, Vienna, AT;
Melitta Bilban, Vienna, AT;
Assignees:
Baxter International Inc., Deerfield, IL (US);
Baxter Healthcare, S.A., Glattpark, CH;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/00 (2006.01); A61K 31/33 (2006.01); A61F 13/00 (2006.01); A61K 38/48 (2006.01); A61L 27/26 (2006.01); A61L 24/00 (2006.01); A61L 24/02 (2006.01); A61L 24/10 (2006.01); A61L 27/12 (2006.01); A61L 27/22 (2006.01); A61L 27/54 (2006.01); A61L 27/58 (2006.01); A61F 2/28 (2006.01); A61F 2/44 (2006.01); A61F 2/46 (2006.01); A61F 2/30 (2006.01);
U.S. Cl.
CPC ...
A61L 27/26 (2013.01); A61L 24/0015 (2013.01); A61L 24/0042 (2013.01); A61L 24/02 (2013.01); A61L 24/106 (2013.01); A61L 24/108 (2013.01); A61L 27/12 (2013.01); A61L 27/225 (2013.01); A61L 27/227 (2013.01); A61L 27/54 (2013.01); A61L 27/58 (2013.01); A61F 2/28 (2013.01); A61F 2/44 (2013.01); A61F 2/4601 (2013.01); A61F 2002/2817 (2013.01); A61F 2002/2828 (2013.01); A61F 2002/30062 (2013.01); A61F 2002/30677 (2013.01); A61F 2210/0004 (2013.01); A61F 2310/00293 (2013.01); A61F 2310/00377 (2013.01); A61L 2300/202 (2013.01); A61L 2300/418 (2013.01); A61L 2300/44 (2013.01); A61L 2300/622 (2013.01); A61L 2400/06 (2013.01); A61L 2430/02 (2013.01);
Abstract
The present invention relates to a biodegradable injectable composition for bone augmentation comprising fibrin, a contrast agent and calcium salt-containing particles, as well as a method for bone augmentation in a patient suffering from a bone disorder comprising injecting said composition into a non-mineralized or hollow portion of said bone.